ABK Biomedical Inc. is pursuing development, production and sale of embolic agents and peripheral vascular delivery devices. ABK innovates integrated devices to simplify clinical procedures performed by interventional radiologists, with the lead system OccluRad /OccluDel, targeting hypervascular tumors including uterine fibroids. ABK BioMedical has developed OccluRad beads and the OccluDel device providing a simpler, safer and more cost effective solution to treating hypervascular tumors.